Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RBI-4000 by Replicate Bioscience for Rabies: Likelihood of Approval
RBI-4000 is under clinical development by Replicate Bioscience and currently in Phase I for Rabies. According to GlobalData, Phase I...